866 related articles for article (PubMed ID: 20837822)
1. Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes.
Baker LD; Cross DJ; Minoshima S; Belongia D; Watson GS; Craft S
Arch Neurol; 2011 Jan; 68(1):51-7. PubMed ID: 20837822
[TBL] [Abstract][Full Text] [Related]
2. Association of Insulin Resistance With Cerebral Glucose Uptake in Late Middle-Aged Adults at Risk for Alzheimer Disease.
Willette AA; Bendlin BB; Starks EJ; Birdsill AC; Johnson SC; Christian BT; Okonkwo OC; La Rue A; Hermann BP; Koscik RL; Jonaitis EM; Sager MA; Asthana S
JAMA Neurol; 2015 Sep; 72(9):1013-20. PubMed ID: 26214150
[TBL] [Abstract][Full Text] [Related]
3. 18F-fluorodeoxyglucose positron emission tomography, aging, and apolipoprotein E genotype in cognitively normal persons.
Knopman DS; Jack CR; Wiste HJ; Lundt ES; Weigand SD; Vemuri P; Lowe VJ; Kantarci K; Gunter JL; Senjem ML; Mielke MM; Roberts RO; Boeve BF; Petersen RC
Neurobiol Aging; 2014 Sep; 35(9):2096-106. PubMed ID: 24702820
[TBL] [Abstract][Full Text] [Related]
4. Preclinical evidence of Alzheimer changes: convergent cerebrospinal fluid biomarker and fluorodeoxyglucose positron emission tomography findings.
Petrie EC; Cross DJ; Galasko D; Schellenberg GD; Raskind MA; Peskind ER; Minoshima S
Arch Neurol; 2009 May; 66(5):632-7. PubMed ID: 19433663
[TBL] [Abstract][Full Text] [Related]
5. A cross-sectional comparison of brain glucose and ketone metabolism in cognitively healthy older adults, mild cognitive impairment and early Alzheimer's disease.
Croteau E; Castellano CA; Fortier M; Bocti C; Fulop T; Paquet N; Cunnane SC
Exp Gerontol; 2018 Jul; 107():18-26. PubMed ID: 28709938
[TBL] [Abstract][Full Text] [Related]
6. Individual cerebral metabolic deficits in Alzheimer's disease and amnestic mild cognitive impairment: an FDG PET study.
Del Sole A; Clerici F; Chiti A; Lecchi M; Mariani C; Maggiore L; Mosconi L; Lucignani G
Eur J Nucl Med Mol Imaging; 2008 Jul; 35(7):1357-66. PubMed ID: 18418593
[TBL] [Abstract][Full Text] [Related]
7. [Characteristics of cerebral glucose metabolism in patients with cognitive impairment in Parkinson's disease].
Homenko JG; Susin DS; Kataeva GV; Irishina JA; Zavolokov IG
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(5):46-51. PubMed ID: 28638030
[TBL] [Abstract][Full Text] [Related]
8. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
Chen Z; Zhong C
Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
[TBL] [Abstract][Full Text] [Related]
9. Insulin resistance predicts medial temporal hypermetabolism in mild cognitive impairment conversion to Alzheimer disease.
Willette AA; Modanlo N; Kapogiannis D;
Diabetes; 2015 Jun; 64(6):1933-40. PubMed ID: 25576061
[TBL] [Abstract][Full Text] [Related]
10. Comparing fludeoxyglucose F18-PET assessment of regional cerebral glucose metabolism and [11C]dihydrotetrabenazine-PET in evaluation of early dementia and mild cognitive impairment.
Albin RL; Koeppe RA; Burke JF; Giordani B; Kilbourn MR; Gilman S; Frey KA
Arch Neurol; 2010 Apr; 67(4):440-6. PubMed ID: 20385910
[TBL] [Abstract][Full Text] [Related]
11. The functional neuroanatomy of verbal memory in Alzheimer's disease: [
Staffaroni AM; Melrose RJ; Leskin LP; Riskin-Jones H; Harwood D; Mandelkern M; Sultzer DL
J Clin Exp Neuropsychol; 2017 Sep; 39(7):682-693. PubMed ID: 27876444
[TBL] [Abstract][Full Text] [Related]
12. The relationship of glucose-stimulated insulin secretion to cerebral glucose metabolism and cognition in healthy middle-aged and older adults.
Ennis GE; Kohli A; Jonaitis EM; Betthauser TJ; Oh JM; Taylor CE; Chin N; Koscik RL; Christian BT; Asthana S; Johnson SC; Bendlin BB
Neurobiol Aging; 2021 Sep; 105():174-185. PubMed ID: 34091125
[TBL] [Abstract][Full Text] [Related]
13. Regional glucose metabolism due to the presence of cerebral amyloidopathy in older adults with depression and mild cognitive impairment.
Youn H; Lee ES; Lee S; Suh S; Jeong HG; Eo JS
J Affect Disord; 2018 Oct; 239():30-36. PubMed ID: 29991443
[TBL] [Abstract][Full Text] [Related]
14. No difference in cerebral glucose metabolism in patients with Alzheimer disease and differing apolipoprotein E genotypes.
Corder EH; Jelic V; Basun H; Lannfelt L; Valind S; Winblad B; Nordberg A
Arch Neurol; 1997 Mar; 54(3):273-7. PubMed ID: 9074396
[TBL] [Abstract][Full Text] [Related]
15. Quantification of Task-Specific Glucose Metabolism with Constant Infusion of 18F-FDG.
Hahn A; Gryglewski G; Nics L; Hienert M; Rischka L; Vraka C; Sigurdardottir H; Vanicek T; James GM; Seiger R; Kautzky A; Silberbauer L; Wadsak W; Mitterhauser M; Hacker M; Kasper S; Lanzenberger R
J Nucl Med; 2016 Dec; 57(12):1933-1940. PubMed ID: 27390156
[TBL] [Abstract][Full Text] [Related]
16. Regional Brain Glucose Hypometabolism in Young Women with Polycystic Ovary Syndrome: Possible Link to Mild Insulin Resistance.
Castellano CA; Baillargeon JP; Nugent S; Tremblay S; Fortier M; Imbeault H; Duval J; Cunnane SC
PLoS One; 2015; 10(12):e0144116. PubMed ID: 26650926
[TBL] [Abstract][Full Text] [Related]
17. Reduced task durations in functional PET imaging with [
Rischka L; Gryglewski G; Pfaff S; Vanicek T; Hienert M; Klöbl M; Hartenbach M; Haug A; Wadsak W; Mitterhauser M; Hacker M; Kasper S; Lanzenberger R; Hahn A
Neuroimage; 2018 Nov; 181():323-330. PubMed ID: 29966719
[TBL] [Abstract][Full Text] [Related]
18. Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial.
Craft S; Baker LD; Montine TJ; Minoshima S; Watson GS; Claxton A; Arbuckle M; Callaghan M; Tsai E; Plymate SR; Green PS; Leverenz J; Cross D; Gerton B
Arch Neurol; 2012 Jan; 69(1):29-38. PubMed ID: 21911655
[TBL] [Abstract][Full Text] [Related]
19. Effects of glucose, insulin, and insulin resistance on cerebral 18F-FDG distribution in cognitively normal older subjects.
Ishibashi K; Onishi A; Fujiwara Y; Ishiwata K; Ishii K
PLoS One; 2017; 12(7):e0181400. PubMed ID: 28715453
[TBL] [Abstract][Full Text] [Related]
20. Interactions among glucose delivery, transport, and phosphorylation that underlie skeletal muscle insulin resistance in obesity and type 2 Diabetes: studies with dynamic PET imaging.
Goodpaster BH; Bertoldo A; Ng JM; Azuma K; Pencek RR; Kelley C; Price JC; Cobelli C; Kelley DE
Diabetes; 2014 Mar; 63(3):1058-68. PubMed ID: 24222345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
